Kedrion Biopharma

Italy (Barga / Bolognana, Lucca); USA (Melville, NY)
Hybrid — also manufactures internal programs
Biologics Sterile Fill-Finish
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (5)

Quick Facts: Kedrion Biopharma

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Italy (Barga / Bolognana, Lucca); USA (Melville, NY)
Website
Modalities
Biologics, Sterile Fill-Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Kedrion Biopharma

Kedrion Biopharma makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Biologics, Sterile Fill-Finish. 3 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.kedrion.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Kedrion Biopharma FDA Inspection History

2025-04
2024-03
2022-06
NAI VAI OAI
Date Site Type Observations Classification
2025-04-30
Kedrion S.p.A.
Barga Company-level
Bioresearch Monitoring No No Action Indicated (NAI)
2024-03-27
Kedrion Biopharma Inc.
Melville, New York Company-level
Blood and Blood Products No Voluntary Action Indicated (VAI)
2022-06-24
Kedrion S.p.A.
Gallicano Company-level
Blood and Blood Products Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Kedrion Biopharma FDA 483 Findings 3 observations · 2022-06-24 → 2022-06-24 ?

By subsystem

  • Equipment & Facilities 2 (66.7%)
  • Documentation & Records 1 (33.3%)

By severity

  • 2 — Minor: 3
  • Repeat observations: 0

Most severe findings

  • Minor (2) Equipment & Facilities 2022-06-24 21 CFR 211.68(a)
    Calibration/Inspection/Checking not done

    "Routine inspection and checking of mechanical equipment is not performed according to a written program designed to assure proper performance."

  • Minor (2) Documentation & Records 2022-06-24 21 CFR 211.100(a)
    Absence of Written Procedures

    "There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess."

  • Minor (2) Equipment & Facilities 2022-06-24 21 CFR 211.67(b)
    Written procedures not established/followed

    "Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Kedrion Biopharma

How many FDA inspections does Kedrion Biopharma have on record?
CDMO Signal tracks 3 FDA inspections for Kedrion Biopharma, sourced from the FDA inspection database. See the full inspection history above.
Has Kedrion Biopharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Kedrion Biopharma.
Does Kedrion Biopharma have a CDMO Signal Score?
Not yet. Kedrion Biopharma is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Kedrion Biopharma for a manufacturing program?
Use the free AI matchmaker to compare Kedrion Biopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs →

Similar CDMOs

GBI (Goodwin Biotechnology)
Plantation, Florida, USA
Biologics, ADC / Bioconjugation, Sterile Fill-Finish
IDT Biologika
Germany
Biologics, Cell & Gene Therapy, Sterile Fill-Finish
Prothya Biosolutions
Amsterdam, Netherlands; Brussels, Belgium
Biologics, Sterile Fill-Finish
Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
BE Biosol
India
Biologics, Sterile Fill-Finish

Compare Kedrion Biopharma with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Kedrion Biopharma
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.